Cabozantinib in Recurrent/Metastatic Merkel Cell Carcinoma
Clinical trial NCT02036476 · TERMINATED
Trial details
- NCT number
- NCT02036476
- Sponsor
- Dana-Farber Cancer Institute
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-02-01
- Primary completion
- 2016-04-01
- Enrollment
- 8
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.